Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade

מאת Buchbinder, Elizabeth, Hodi, F. Stephen
הוצא לאור ב J Clin Invest (2015)

CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition

מאת Buchbinder, Elizabeth I., Desai, Anupam
הוצא לאור ב Am J Clin Oncol (2016)

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial...

מאת Ott, Patrick A., Hodi, F. Stephen, Buchbinder, Elizabeth I.
הוצא לאור ב Front Oncol (2015)

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

מאת Naik, Girish S., Waikar, Sushrut S., Johnson, Alistair E. W., Buchbinder, Elizabeth I., Haq, Rizwan, Hodi, F. Stephen, Schoenfeld, Jonathan D., Ott, Patrick A.
הוצא לאור ב J Immunother Cancer (2019)

Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: Identifying markers for clinical outcome and treatment decisions

מאת Nishino, Mizuki, Giobbie-Hurder, Anita, Manos, Michael P., Bailey, Nancy D., Buchbinder, Elizabeth I., Ott, Patrick A., Ramaiya, Nikhil H., Hodi, F. Stephen
הוצא לאור ב Clin Cancer Res (2017)

Su1188 ABDOMINAL CT SHOULD NOT BE USED TO SCREEN FOR IMMUNE CHECKPOINT INHIBITOR COLITIS

מאת Braschi-Amirfarzan, Marta, Ruan, Alex, Srivastava, Amitabh, Gannarapu, Swetha, Raj, Dhanya, Giobbie-Hurder, Anita, Buchbinder, Elizabeth, Ott, Patrick, Hodi, F. Stephen, Rahma, Osama, Grover, Shilpa
הוצא לאור ב Gastroenterology (2020)

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma

מאת Ibrahim, Nageatte, Buchbinder, Elizabeth I., Granter, Scott R., Rodig, Scott J., Giobbie‐Hurder, Anita, Becerra, Carla, Tsiaras, Argyro, Gjini, Evisa, Fisher, David E., Hodi, F. Stephen
הוצא לאור ב Cancer Med (2016)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS

מאת Grover, Shilpa, Ruan, Alex, Srivoleti, Padma, Giobbie-Hurder, Anita, Braschi-Amirfarzan, Marta, Srivastava, Amitabh, Buchbinder, Elizabeth, Ott, Patrick, Hodi, F. Stephen, Kehl, Kenneth, Awad, Mark, Rahma, Osama
הוצא לאור ב Gastroenterology (2020)

A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade

מאת Miller, Peter G., Sperling, Adam S., Gibson, Christopher J., Pozdnyakova, Olga, Wong, Waihay J., Manos, Michael P., Buchbinder, Elizabeth I., Hodi, F. Stephen, Ebert, Benjamin L., Davids, Matthew S.
הוצא לאור ב Haematologica (2020)

Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)

מאת Sun, James, Gastman, Brian R, McCahon, Lucy, Buchbinder, Elizabeth I, Puzanov, Igor, Nanni, Michele, Lewis, James M, Carvajal, Richard D, Singh-Kandah, Shahnaz, Desai, Anupam M, Raskin, Leon, Nielson, Carrie M, Ismail, Rubina, Zager, Jonathan S
הוצא לאור ב Melanoma Manag (2020)

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade

מאת Buchbinder, Elizabeth I., Weirather, Jason L., Manos, Michael, Quattrochi, Brian J., Sholl, Lynette M., Brennick, Ryan C., Bowling, Peter, Bailey, Nancy, Magarace, Lisa, Ott, Patrick A., Haq, Rizwan, Izar, Benjamin, Giobbie‐Hurder, Anita, Hodi, F. Stephen
הוצא לאור ב Cancer Med (2021)

Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

מאת Gogas, Helen, Dafni, Urania, Koon, Henry, Spyropoulou-Vlachou, Maria, Metaxas, Yannis, Buchbinder, Elizabeth, Pectasides, Eirini, Tsoutsos, Dimosthenis, Polyzos, Aristidis, Stratigos, Alexandros, Markopoulos, Christos, Panagiotou, Petros, Fountzilas, George, Castana, Ourania, Skarlos, Pantelis, Atkins, Michael B, Kirkwood, John M
יצא לאור 2010

Clinical features of acquired resistance to anti–PD-1 therapy in advanced melanoma

מאת Wang, Daniel Y., Eroglu, Zeynep, Ozgun, Alpaslan, Leger, Paul D., Zhao, Shilin, Ye, Fei, Luke, Jason J., Joseph, Richard W., Haq, Rizwan, Ott, Patrick A., Hodi, F. Stephen, Sosman, Jeffrey A., Johnson, Douglas B., Buchbinder, Elizabeth I.
הוצא לאור ב Cancer Immunol Res (2017)

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

מאת Lee, Hyunju, Hodi, F. Stephen, Giobbie-Hurder, Anita, Ott, Patrick A., Buchbinder, Elizabeth I., Haq, Rizwan, Tolaney, Sara, Barroso-Sousa, Romualdo, Zhang, Kevin, Donahue, Hilary, Davis, Meredith, Gargano, Maria E., Kelley, Kristina M., Carroll, Rona S., Kaiser, Ursula B., Min, Le
הוצא לאור ב Cancer Immunol Res (2017)

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial

מאת Weber, Jeffrey S, Gibney, Geoff, Sullivan, Ryan J, Sosman, Jeffrey A, Slingluff, Craig L, Lawrence, Donald P, Logan, Theodore F, Schuchter, Lynn M, Nair, Suresh, Fecher, Leslie, Buchbinder, Elizabeth I, Berghorn, Elmer, Ruisi, Mary, Kong, George, Jiang, Joel, Horak, Christine, Hodi, F Stephen
הוצא לאור ב Lancet Oncol (2016)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

מאת Buchbinder, Elizabeth I., Dutcher, Janice P., Daniels, Gregory A., Curti, Brendan D., Patel, Sapna P., Holtan, Shernan G., Miletello, Gerald P., Fishman, Mayer N., Gonzalez, Rene, Clark, Joseph I., Richart, John M., Lao, Christopher D., Tykodi, Scott S., Silk, Ann W., McDermott, David F.
הוצא לאור ב J Immunother Cancer (2019)

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma

מאת Buchbinder, Elizabeth I., Gunturi, Anasuya, Perritt, Jessica, Dutcher, Janice, Aung, Sandra, Kaufman, Howard L., Ernstoff, Marc S., Miletello, Girald P., Curti, Brendan D., Daniels, Gregory A., Patel, Sapna P., Kirkwood, John M., Hallmeyer, Sigrun, Clark, Joseph I., Gonzalez, Rene, Richart, John M., Lutzky, Joe, Morse, Michael A., Sullivan, Ryan J., McDermott, David F.
הוצא לאור ב J Immunother Cancer (2016)

Vitamin D Intake is Associated with Decreased Risk of Immune Checkpoint Inhibitor-Induced Colitis

מאת Grover, Shilpa, Dougan, Michael, Tyan, Kevin, Giobbie-Hurder, Anita, Blum, Steven M., Ishizuka, Jeffrey, Qazi, Taha, Elias, Rawad, Vora, Kruti B., Ruan, Alex B., Martin-Doyle, William, Manos, Michael, Eastman, Lauren, Davis, Meredith, Gargano, Maria, Haq, Rizwan, Buchbinder, Elizabeth I., Sullivan, Ryan J., Ott, Patrick A., Hodi, F. Stephen, Rahma, Osama E.
הוצא לאור ב Cancer (2020)

Clinical utility of a blood-based BRAF V600E mutation assay in melanoma

מאת Panka, David J, Buchbinder, Elizabeth, Giobbie-Hurder, Anita, Schalck, Aislyn P, Montaser-Kouhsari, Laleh, Sepehr, Alireza, Lawrence, Donald P., McDermott, David F., Cohen, Rachel, Carlson, Alexander, Wargo, Jennifer A, Merritt, Ryan, Seery, Virginia J., Hodi, F. Stephen, Gunturi, Anasuya, Fredrick, Dennie, Atkins, Michael B., Iafrate, A. John, Flaherty, Keith T., Mier, James W, Sullivan, Ryan J
הוצא לאור ב Mol Cancer Ther (2014)

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

מאת Johnson, Douglas B., McDonnell, Wyatt J., Ericsson-Gonzalez, Paula I., Al-Rohil, Rami, Mobley, Bret C., Salem, Joe-Elie, Wang, Daniel Y., Sanchez, Violeta, Wang, Yu, Chastain, Cody A., Barker, Kristi, Liang, Yan, Warren, Sarah, Beechem, Joseph, Menzies, Alexander M., Tio, Martin, Long, Georgina V., Cohen, Justine V., Guidon, Amanda C., O’Hare, Méabh, Chandra, Sunandana, Chowdhary, Akansha, Lebrun-Vignes, Benedicte, Goldinger, Simone, Rushing, Elisabeth, Buchbinder, Elizabeth, Mallal, Simon A., Shi, Chanjuan, Xu, Yaomin, Moslehi, Javid J., Sanders, Melinda E., Sosman, Jeffrey A., Balko, Justin M.
הוצא לאור ב Nat Med (2019)